Haemonetics Corp (FRA:HAZ)
€ 78.5 -0.5 (-0.63%) Market Cap: 3.97 Bil Enterprise Value: 4.85 Bil PE Ratio: 34.58 PB Ratio: 4.78 GF Score: 28/100

Q2 2021 Haemonetics Corp Earnings Call Transcript

Nov 04, 2020 / 01:00PM GMT
Release Date Price: €86
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Haemonetics Second Quarter Fiscal '21 Conference Call and Webcast. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Ms. Olga Guyette, Investor Relations. Ma'am, you may begin.

Olga Guyette
Haemonetics Corporation - Director of IR

Good morning, everyone. Thank you for joining us for Haemonetics' Second Quarter Fiscal '21 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; and Bill Burke, our CFO. This morning, we posted our second quarter and first half fiscal '21 results to our Investor Relations website including the analytical tables with the information that we'll refer to on this call. Additionally, we provided the complete P&L, balance sheet, summary statement of cash flows as well as reconciliations of our GAAP to non-GAAP financial results. Before we get started, unless otherwise noted, all revenue growth rates discussed today are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot